KR101714543B1 - Aroma composition for psycholigical stability and reducing stress comprising Schisandra chinensis essential oil and Angelica gigas essential oil as effective component - Google Patents
Aroma composition for psycholigical stability and reducing stress comprising Schisandra chinensis essential oil and Angelica gigas essential oil as effective component Download PDFInfo
- Publication number
- KR101714543B1 KR101714543B1 KR1020160112927A KR20160112927A KR101714543B1 KR 101714543 B1 KR101714543 B1 KR 101714543B1 KR 1020160112927 A KR1020160112927 A KR 1020160112927A KR 20160112927 A KR20160112927 A KR 20160112927A KR 101714543 B1 KR101714543 B1 KR 101714543B1
- Authority
- KR
- South Korea
- Prior art keywords
- essential oil
- cream
- omija
- alpha
- power spectrum
- Prior art date
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 65
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 235000018865 Angelica gigas Nutrition 0.000 title abstract description 14
- 240000001810 Angelica gigas Species 0.000 title abstract description 14
- 235000008422 Schisandra chinensis Nutrition 0.000 title abstract description 4
- 240000006079 Schisandra chinensis Species 0.000 title abstract description 4
- 238000001228 spectrum Methods 0.000 claims abstract description 43
- 230000003595 spectral effect Effects 0.000 claims abstract description 16
- 102100021709 Rho guanine nucleotide exchange factor 4 Human genes 0.000 claims abstract description 13
- 101710128386 Rho guanine nucleotide exchange factor 4 Proteins 0.000 claims abstract description 13
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 230000007423 decrease Effects 0.000 claims abstract description 5
- 239000002304 perfume Substances 0.000 claims description 28
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims description 28
- 239000000796 flavoring agent Substances 0.000 claims description 15
- 235000019634 flavors Nutrition 0.000 claims description 15
- 239000003921 oil Substances 0.000 claims description 13
- 210000001152 parietal lobe Anatomy 0.000 claims description 13
- 239000006071 cream Substances 0.000 claims description 12
- 239000006210 lotion Substances 0.000 claims description 11
- 239000002537 cosmetic Substances 0.000 claims description 8
- 235000016709 nutrition Nutrition 0.000 claims description 8
- 241000092897 Angelica japonica Species 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 210000002442 prefrontal cortex Anatomy 0.000 claims description 6
- 235000013376 functional food Nutrition 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 229920002230 Pectic acid Polymers 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 235000014171 carbonated beverage Nutrition 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 claims description 2
- 239000010318 polygalacturonic acid Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 239000004902 Softening Agent Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000000084 colloidal system Substances 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 230000009467 reduction Effects 0.000 abstract description 4
- 241001582888 Lobus Species 0.000 abstract 2
- 239000003205 fragrance Substances 0.000 description 37
- 210000004556 brain Anatomy 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 235000013599 spices Nutrition 0.000 description 11
- 230000002123 temporal effect Effects 0.000 description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 230000001936 parietal effect Effects 0.000 description 10
- 230000002360 prefrontal effect Effects 0.000 description 10
- 235000001287 Guettarda speciosa Nutrition 0.000 description 8
- 210000003710 cerebral cortex Anatomy 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 241001400472 Omiza Species 0.000 description 6
- 230000007177 brain activity Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 230000003340 mental effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 5
- 241000207199 Citrus Species 0.000 description 5
- 238000000692 Student's t-test Methods 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 235000020971 citrus fruits Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000012353 t test Methods 0.000 description 5
- 244000061520 Angelica archangelica Species 0.000 description 4
- 235000007516 Chrysanthemum Nutrition 0.000 description 4
- 240000002045 Guettarda speciosa Species 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 210000001652 frontal lobe Anatomy 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 244000061408 Eugenia caryophyllata Species 0.000 description 3
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007405 data analysis Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 210000000869 occipital lobe Anatomy 0.000 description 3
- 238000001256 steam distillation Methods 0.000 description 3
- 241000382455 Angelica sinensis Species 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 2
- 244000130592 Hibiscus syriacus Species 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 244000184734 Pyrus japonica Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- UIERETOOQGIECD-ARJAWSKDSA-N angelic acid group Chemical group C(\C(\C)=C/C)(=O)O UIERETOOQGIECD-ARJAWSKDSA-N 0.000 description 2
- 230000037007 arousal Effects 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000000537 electroencephalography Methods 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 230000007334 memory performance Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 210000000196 olfactory nerve Anatomy 0.000 description 2
- 210000002475 olfactory pathway Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 210000003478 temporal lobe Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001103 thalamus Anatomy 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WEFHSZAZNMEWKJ-KEDVMYETSA-N (6Z,8E)-undeca-6,8,10-trien-2-one (6E,8E)-undeca-6,8,10-trien-2-one (6Z,8E)-undeca-6,8,10-trien-3-one (6E,8E)-undeca-6,8,10-trien-3-one (6Z,8E)-undeca-6,8,10-trien-4-one (6E,8E)-undeca-6,8,10-trien-4-one Chemical compound CCCC(=O)C\C=C\C=C\C=C.CCCC(=O)C\C=C/C=C/C=C.CCC(=O)CC\C=C\C=C\C=C.CCC(=O)CC\C=C/C=C/C=C.CC(=O)CCC\C=C\C=C\C=C.CC(=O)CCC\C=C/C=C/C=C WEFHSZAZNMEWKJ-KEDVMYETSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 235000003074 Acacia farnesiana Nutrition 0.000 description 1
- 244000020998 Acacia farnesiana Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 244000263228 Angelica sp Species 0.000 description 1
- 235000008490 Angelica sp Nutrition 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 235000006295 Chrysanthemum sp Nutrition 0.000 description 1
- 241000974977 Chrysanthemum sp. Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 description 1
- 241000116713 Ferula gummosa Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282375 Herpestidae Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 208000020358 Learning disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000304222 Melaleuca cajuputi Species 0.000 description 1
- 235000001167 Melaleuca cajuputi Nutrition 0.000 description 1
- 235000017710 Melaleuca viridiflora Nutrition 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 208000036822 Small cell carcinoma of the ovary Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 235000007769 Vetiveria zizanioides Nutrition 0.000 description 1
- 244000284012 Vetiveria zizanioides Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 235000020831 absolute fast Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- SWUIQEBPZIHZQS-UHFFFAOYSA-N calone Chemical compound O1CC(=O)COC2=CC(C)=CC=C21 SWUIQEBPZIHZQS-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 229940093503 ethyl maltol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000004864 galbanum Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 230000008449 language Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000956 olfactory bulb Anatomy 0.000 description 1
- 210000001706 olfactory mucosa Anatomy 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 201000005292 ovarian small cell carcinoma Diseases 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940035637 spectrum-4 Drugs 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000000857 visual cortex Anatomy 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
- 239000012855 volatile organic compound Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/12—Natural spices, flavouring agents or condiments; Extracts thereof from fruit, e.g. essential oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
본 발명은 오미자 정유 및 참당귀 정유를 유효성분으로 함유하는 심리적 안정 및 스트레스 완화용 향료 조성물에 관한 것이다.The present invention relates to a perfume composition for psychological stability and stress relief comprising an essential oil of Omija essential oil and true angelica essential oil as an active ingredient.
대뇌는 인간의 전체 뇌 용적의 75% 이상을 차지하고 있으며, 좌우반구로 나뉘어져 있다. 대뇌의 표면인 대뇌피질은 둥글게 튀어나온 이랑과 파인 부분인 고랑으로 주름진 모양을 하고 있는데 영역에 따라 전두엽, 두정엽, 측두엽, 후두엽으로 나뉜다. 대뇌 피질은 영역별로 특정한 기능을 하는 것으로 알려져 있는데, 전두엽은 인간의 뇌를 구성하는 엽 중에서 가장 크며 의식을 조절하고 통제하는 영역으로 주의집중, 기억, 언어, 집행기능, 성격 및 정서, 감정의 인식, 추론과 판단, 의사결정 등 인지기능과 관련이 있다. 두정엽은 척수의 등 쪽 경로를 통해 전달되는 감각신호를 종합하여 몸의 거리 및 위치를 측정하는 공간지각기능을 담당하며 부분기억, 주의집중에도 관여한다. 후두엽은 시각 피질이 위치해 있으며 사물의 인식을 담당한다. The cerebrum accounts for more than 75% of the total human brain volume, and is divided into left and right hemispheres. The cerebral cortex, which is the surface of the cerebral cortex, is a corrugated shape with a round protruding ridge and a fine ridge. Depending on the area, it is divided into frontal lobe, parietal lobe, temporal lobe, and occipital lobe. The cerebral cortex is known to have a specific function in each region. The frontal lobe is the largest among the leaves constituting the human brain, and is a region to control and control consciousness. It is a region of attention, memory, language, executive function, personality and emotion, , Reasoning and judgment, and decision making. The parietal lobe functions as a spatial perception function that measures the distance and position of the body by integrating sensory signals transmitted through the dorsal path of the spinal cord, and is involved in partial memory and attention. The occipital lobe is located in the visual cortex and is responsible for recognizing things.
또한, 대뇌 피질은 인간의 감각인 시각, 청각, 미각, 후각 반응을 하는데, 특히 후각은 음식의 식별, 섭식의 인지, 위험의 감지, 동료 및 부모의 인지 등의 역할을 하는 것으로 알려져 있다(Mori K, Takahashi YK., Igarashi K.M.,Yamaguchi M. (2006) Maps of odorant molecular features in the mammalian olfactory bulb. Physiol Rev 86:409-433) 인간이 향을 맡는 과정은 먼저 냄새 분자가 비강을 통과하여 후각 상피에 도달하고, 후각 상피에 있는 후각 신경세포가 이를 감지하여 뇌에 전기적인 신호를 전달하는 것으로 알려져 있다. 후각 신경세포에서 발생한 신호는 후각 망울에서 해석된 후, 두 가지 후각신호 전달로를 통해 뇌에서 인지되는데 하나는 시상을 거치지 않고 편도 핵과 가측 시상하부를 거쳐 대뇌피질로 전달되는 경로이고, 또 다른 하나는 후각 피질(조롱박 피질, pyriform cortex)을 거치는 경로로 시상을 거쳐 대뇌피질로 전달되는 경로이다(Zetorre et al. (1992) Functioanl localization and lateralization of human olfactory cortex. Letters to Nature 360:339-340). In addition, the cerebral cortex plays a role in the human sense of sight, hearing, taste, and smell, especially the smell plays a role in identification of food, recognition of feeding, detection of danger, recognition of peers and parents (Mori Physiol Rev 86: 409-433) The process by which humans take the fragrance is that the odor molecules pass through the nasal passages first, and then to the olfactory nerves It reaches the epithelium, and the olfactory nerve cell in the olfactory epithelium senses it and transmits an electrical signal to the brain. The signal from the olfactory neuron is interpreted in the olfactory bulb and then recognized in the brain via two olfactory signal pathways, one pathway through the tonsil nucleus and the lateral hypothalamus to the cerebral cortex without passing through the thalamus, another Is a pathway through the olfactory cortex (the gourd cortex) through the thalamus to the cerebral cortex (Zetorre et al. (1992) Localization and lateralization of human olfactory cortex. Letters to Nature 360: 339-340) .
냄새 분자가 대뇌피질에 후각신호를 전달하면 신경세포에서는 끊임없이 미세한 전기활동이 일어나는데, 이때 대뇌 피질 표면을 덮고 있는 두피 위에서 전기적 전위변동이 일어나는데 이를 측정한 것이 뇌파이다. When the odorant molecules transmit the olfactory signal to the cerebral cortex, the nerve cells are constantly subjected to minute electrical activity, in which electric potential fluctuations occur on the scalp covering the surface of the cerebral cortex.
두피 위에 전극을 부착하고, 두뇌에서 발생한 전기신호를 뇌파계에 입력시켜 시간에 따른 전위를 기록해서 얻는 결과물을 뇌파 혹은 뇌전도(electroencephalogram, EEG)라고 하는데(진복희 (2011) 임상생리학 뇌파. 고려의학. p.1), 뇌파는 시시각각으로 변화하는 뇌 활동의 변동을 시공간적으로 기록할 수 있고, 비침습적, 연속적으로 간단하게 뇌의 기능을 측정할 수 있어서 뇌 활동기록, 질병진단, 수면연구, 심리치료와 같은 인지과학, 의학, 약학 분야에서 폭넓게 활용되고 있다(윤중수 (2010) 임상뇌파학. 고려의학. p.1-77).The electroencephalogram (EEG) is an electroencephalogram (EEG) that is obtained by attaching an electrode on the scalp and inputting electrical signals generated from the brain into the brain wave system to record the time potential. p. 1), EEG is able to record temporal and spatial changes of brain activity changing instantaneously, and it can measure brain function non-invasively, continuously, and it can record brain activity record, disease diagnosis, sleep study, (2010) Clinical Electroencephalography, Koryo Medicine, p. 1-77).
최근 뇌-컴퓨터 인터페이스(Brain-Computer Interface)를 이용하여 뇌파를 통해 인간이 어떤 생각을 하고 있는지를 판독하고, 로봇 팔과 로봇 의자를 조정하는데도 활용되고 있다.Recently, brain-computer interface (Brain-Computer Interface) has been used to read human's thoughts through brain waves and to adjust robot arm and robot chair.
인간의 뇌파는 주로 5~300μV의 진폭과 0~60Hz 사이의 주파수를 갖는데 주파수의 범위에 따라 델타(delta)파 (0.5~3Hz), 세타(theta)파 (4~7Hz), 알파(alpha) 파(8~13Hz), 베타(beta)파 (14~30Hz), 감마(gamma)파 (30Hz 이상)로 구분한다. 알파(alpha)파를 기준으로 알파파보다 주파수가 작은 델타파와 세타파를 서파(slow wave)라고 하고, 알파파 보다 주파수가 큰 베타파와 감마파를 속파(fast wave)라고 한다. 보통 서파는 진폭이 높고 수면 기간에나 뇌의 활동이 저하되었을 때 나타나고, 속파는 진폭이 낮고 뇌의 활동이 촉진되었을 때 주로 나타난다. 알파파는 기본파이며 주파수는 8~13Hz, 진폭은 10~150μV로 두정엽과 특히 후두엽에서 잘 기록되며 정상 성인의 각성, 안정, 폐안 상태에서 보인다. 베타파는 14~30Hz의 속파(fast wave)로 5~10μV의 낮은 진폭을 가지며 일반적인 작업을 하거나 의식적인 행동을 할 때 나타나며 정보처리와 같은 정신활동이 있을 때 활성화된다. 감마파는 30~50Hz의 주파수 영역에 해당 되며, 뇌파 중에서 가장 빠르게 진동한다. 정서적으로 초조하거나 긴장할 때, 또 추리, 판단 등의 능동적인 고도의 복합정신기능을 수행할 때에도 나타난다(이사은 (2011) 라임향과 클로브향이 뇌파에 미치는 영향. 강원대학교 석사학위논문). Human brainwaves have amplitudes of 5 to 300 μV and frequencies between 0 and 60 Hz. Delta waves (0.5 to 3 Hz), theta waves (4 to 7 Hz), and alpha (8 ~ 13Hz), beta waves (14 ~ 30Hz), and gamma waves (30Hz and above). Delta waves and seta waves with a frequency lower than that of an alpha wave are referred to as slow waves, and beta waves and gamma waves with a frequency greater than that of an alpha wave are referred to as fast waves. Normally, the slow waves occur when the amplitude is high and the brain activity is decreased during the sleeping period, and the fast wave is mainly seen when the amplitude is low and the brain activity is promoted. Alpha wave is a fundamental wave, frequency is 8 ~ 13Hz, amplitude is 10 ~ 150μV and well recorded in parietal lobe and especially occipital lobe. A beta wave is a fast wave of 14-30 Hz with a low amplitude of 5-10 μV and appears when performing normal tasks or conscious actions and is activated when there is mental activity such as information processing. The gamma wave corresponds to the frequency range of 30 to 50 Hz and oscillates most rapidly among EEG waves. (Lee, 2011) Effects of Lime and Clove Fragments on EEG: An Analysis of the Effects of Lime and Clove on Brain Waves, Master Thesis, Kangwon National University, Seoul, Korea.
냄새분자가 모여 특정한 물리적, 화학적 성질을 갖는 것을 정유(essentail oil)라고 하는데, 대부분의 정유는 분자량이 26-300g/mol 정도이고, 비중은 1.0 전후이고 성상은 액상과 고상인 것으로 알려져 있다. 이들의 특성은 일반적으로 휘발성이 강하고, 물에는 녹지 않으나 알코올에는 잘 녹고 다양한 관능기를 가지고 있는 것으로 알려져 있다. It is known that essence oil has a specific physical and chemical properties by gathering odor molecules. Most essential oils have a molecular weight of about 26-300 g / mol, a specific gravity of about 1.0, and the properties are known to be liquid phase and solid phase. Their properties are generally volatile, they are not soluble in water but are well soluble in alcohol and have a variety of functional groups.
한편, 오미자(Schisandra chinensis)는 공 모양으로 지름 약 1cm이고 짙은 붉은 빛깔이다. 속에는 붉은 즙과 불그스레한 갈색 종자가 1~2개 들어 있다. 단맛, 신맛, 쓴맛, 짠맛, 매운맛의 5가지 맛이 나며, 그 중에서도 신맛이 강하다. 오미자에는 시잔드린, 고미신, 시트럴, 사과산, 시트르산 등의 성분이 들어 있어, 심장을 강하게 하고 혈압을 내리며 면역력을 높여 주어 강장제로 사용한다. 폐기능을 강하게 하고 진해, 거담 작용이 있어서 기침이나 갈증 등을 치료하는 데 도움이 된다. 말린 열매를 찬물에 마가 붉게 우러난 물에 꿀, 설탕을 넣어 음료로 마시거나 화채나 녹말편을 만들어 먹는다. 밤, 대추, 미삼을 함께 넣고 끓여 차를 만들거나 술을 담그기도 한다. Meanwhile, Schisandra chinensis ) is a ball with a diameter of about 1cm and a dark red color. It contains one to two reddish juice and reddish brown seeds. It has five flavors: sweet, sour, bitter, salty, and spicy. Omija contains ingredients such as iszindrin, gomilin, citral, malic acid, and citric acid, and strengthens the heart, lowers the blood pressure, increases the immunity, and is used as a tonic. It strengthens the pulmonary function, and it helps to cure the cough and thirst by the deep sea bream and the geodam function. I put the dried fruit in the cold water, and I put the honey and the sugar in the water which is red, and drink it with a drink, and it makes it to eat a leaf or a starch piece. Chestnuts, jujube, and mushrooms are put together and boiled to make tea or soak.
한편, 참당귀(Angelica gigas)는 산골짜기 냇가 근처에서 자란다. 높이 1∼2m이고 전체에 자줏빛이 돈다. 뿌리는 크며 향기가 강하고 줄기는 곧게 선다. 뿌리잎과 밑부분의 잎은 1∼3회 깃꼴겹잎이다. 작은 잎은 3개로 완전히 갈라진 다음 다시 2∼3개로 갈라지고 가장자리에 뾰족한 톱니가 있으며 뒷면은 흰색이다. 끝의 작은 잎에 작은 잎자루가 있다. 윗부분의 잎은 잎몸이 퇴화하고 잎집이 타원형으로 커진다. 꽃은 8∼9월에 피고 자줏빛이고, 꽃잎은 긴 타원형으로 5장이며, 끝이 뾰족하고 5개의 수술이 있다. 총포는 1∼2개이고 잎집처럼 커지며 소총포는 실처럼 가늘고 5∼7개이다. 열매는 10월에 맺으며 타원형이고 가장자리에 날개가 있으며 능선 사이에 유관(油管)이 1개씩 있다. 어린순을 나물로 식용하고 뿌리를 당귀라고 하며 약제로 사용한다. 당귀는 중국산을 안젤리카 시넨시스(A. sinensis), 일본산을 왜당귀, 한국산을 참당귀라고 한다. 한국·중국·일본 등지에 분포한다. On the other hand, Angelica gigas grows near the stream valley. It is 1 ~ 2m in height and purple in the whole. The roots are large and fragrant, and the stems are straight. The leaves of the root and the bottom are 1-3 times haploid leaf. The small leaf is completely divided into 3 pieces and then divided into 2 to 3 again, with sharp sawtooth on the edge and white on the back. There is a small petiole on the small leaf of the tip. The leaf on the upper part is degenerated and the sheath becomes elliptical. Flower is bloomed from August to September and purple. Petal is 5 long oval, with pointed end and 5 stamens. There are 1 ~ 2 guns and it grows like a leaf sheath. The guns are thin like thread and 5 ~ 7. The fruit grows in October, is oval, has wings on the edge, and there is one oil pipe between the ridges. The young seeds are edible as herbs, the roots are called angelica, and they are used as medicines. Angelica sinensis (Angelica sinensis) from China, Angelica japonica, and Angelica japonica from Korea are called Angelica gigas. It is distributed in Korea, China, and Japan.
오미자 또는 참당귀 관련 기술로, 한국공개특허 제2003-0080107호에 스트레스로 인해 발생되는 기억력 감퇴를 억제하고 기억력을 증진시킬 수 있는, 당귀 추출물을 함유하는 기억력 증진용 식품 소재에 관한 기술이 개시되어 있으며, 한국공개특허 제2015-0028104호에 참당귀, 원지, 석창포 및 백복령의 한방복합추출물을 유효성분으로 함유하는 학습 장애 또는 기억력 장애의 예방 또는 치료용 조성물에 관해 개시되어 있고, 한국등록특허 제0804480호에 기억력 증진 조성물에 대하여 개시되어 있으나, 아직까지는 오미자 정유 및 참당귀 정유를 유효성분으로 함유하는 심리적 안정 및 스트레스 완화용 향료 조성물에 대하여 개시된 바 없다.Korean Patent Laid-Open Publication No. 2003-0080107 discloses a technique for suppressing memory decline caused by stress and improving memory performance by a technique related to Omija or Chrysanthemum morifolium. Korean Patent Laid-Open Publication No. 2015-0028104 discloses a composition for preventing or treating a learning disorder or memory disorder containing an extract of Oriental japonica, Oriental japonica, 0804480 discloses a composition for improving memory performance. However, no perfume composition for psychological stability and stress relief has yet been disclosed which contains an essential oil of Omija essential oil and a true angelica essential oil as an active ingredient.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명은 오미자 정유 및 참당귀 정유 복합물을 유효성분으로 함유하는 심리적 안정 및 스트레스 완화용 향료 조성물을 제공하고, 본 발명의 유효성분인 오미자 정유 및 참당귀 정유 복합물을 흡입(inhalation) 하였을 때, 좌측 두정엽에서 RFA(Relative fast alpha power spectrum) 및 ASEF(Spectral edge frequency 50% of alpha spectrum band)의 증가를 유도하고, 우측 두정엽에서 RLB(Relative low beta power spectrum) 및 RST(Ratio of SMR to theta)의 증가를 유도하며, 좌측 전전두엽에서 SEF90(Spectral edge frequency 90%)의 감소를 유도하는 것을 확인함으로써, 본 발명을 완성하였다.The present invention provides a perfume composition for psychological stability and stress relief comprising an essential oil component of Omija essential oil and Angelica gigas Nakai as an active ingredient, Inhalation of true Angelica japonica complex induces an increase in RFA (relative fast alpha power spectrum) and ASEF (50% of alpha spectrum band) in the left parietal lobe and RLB (Relative low beta power spectrum and RST (Ratio of SMR to theta) of the left prefrontal cortex and induce a reduction of SEF90 (90% of spectral edge frequency) in the left prefrontal cortex.
상기 목적을 달성하기 위하여, 본 발명은 오미자 정유 및 참당귀 정유 복합물을 유효성분으로 함유하는 심리적 안정 및 스트레스 완화용 향료 조성물을 제공한다.In order to achieve the above object, the present invention provides a psychological stability and a perfume composition for stress relief comprising an essential oil component of Omija essential oil and Angelica gigas Nakai as an active ingredient.
또한, 본 발명은 상기 향료 조성물을 포함하는 심리적 안정 및 스트레스 완화용 건강기능식품을 제공한다.The present invention also provides a health functional food for psychological stability and stress relief comprising the perfume composition.
또한, 본 발명은 상기 향료 조성물을 포함하는 심리적 안정 및 스트레스 완화용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for psychological stability and stress relief comprising the perfume composition.
본 발명은 오미자 정유 및 참당귀 정유를 유효성분으로 함유하는 심리적 안정 및 스트레스 완화용 향료 조성물에 관한 것으로, 본 발명의 오미자 정유와 참당귀 정유의 조합향료를 흡입하였을 때, 좌측 두정엽에서 RFA(Relative fast alpha power spectrum) 및 ASEF(Spectral edge frequency 50% of alpha spectrum band)의 증가를 유도하고, 우측 두정엽에서 RLB(Relative low beta power spectrum) 및 RST(Ratio of SMR to theta)의 증가를 유도하며, 좌측 전전두엽에서 SEF90(Spectral edge frequency 90%)의 감소를 유도하여 심리적 안정 및 스트레스를 완화하는 효과를 얻을 수 있다. 발명의 조성물은 향장 향료(fragrance)와 식품향료(flavor) 원료뿐만 아니라, 식품에 첨가하여 심리적 안정을 유도하는 스트레스 완화 기능의 뉴로푸드(NeuroFood)를 개발하는데 제공할 수 있다.The present invention relates to a perfume composition for psychological stability and stress relief comprising an essential oil of Omija essential oil and true angelica essential oil as an active ingredient. When the combined perfume of the present invention is inhaled, the RFA (Relative (RLB) and RST (Ratio of SMR to theta) in the right parietal lobe. In addition, In the left prefrontal cortex, the reduction of SEF90 (90% of the spectral edge frequency) is induced, and psychological stability and stress are alleviated. The composition of the present invention can provide not only flavor fragrance and food flavor raw materials but also to develop a stress-relieving neurofood which is added to foods to induce psychological stability.
유 1은 본 발명에 사용된 오미자 열매 시료(A)와 참당귀 뿌리 시료(B)의 사진이다.
도 2는 뇌파측정을 위해 인간의 두뇌에 전극을 붙이는 부위를 제시한 10~20 국제표준 전극부착법을 보여주는 사진이다.[0035] Reference 1 is a photograph of the Omiza fruit sample (A) and the Angelica sp. Root sample (B) used in the present invention.
FIG. 2 is a photograph showing a method for attaching an electrode to a human brain for EEG measurement.
본 발명은 오미자 정유 및 참당귀 정유 복합물을 유효성분으로 함유하는 심리적 안정 및 스트레스 완화용 향료 조성물을 제공한다.The present invention provides a perfume composition for psychological stability and stress relief containing an essential oil component of Omija essential oil and Angelica gigas Nakai as an active ingredient.
본 발명에서 정유(essential oil)란 식물의 잎, 줄기, 열매, 뿌리, 꽃에서 다양한 방법으로 추출한 휘발성의 유기화합물을 통칭하는 것으로, 상기 오미자 정유는 오미자 열매 증류 추출물로부터 획득한 정유이고, 상기 참당귀 정유는 참당귀 뿌리 초임계 이산화탄소 추출물로부터 획득한 정유인 것이 바람직하며, 그 이외의 방법으로 추출한 정유는 향취가 상이하여 부적합하다.In the present invention, essential oil is a volatile organic compound extracted from leaves, stems, fruits, roots and flowers of plants by various methods. The essential oil is an essential oil obtained from a distillation extract of Omiza fruit, It is preferable that the essential oil extracted from the root extract of Angelica gigas Nakai is supercritical carbon dioxide, and the essential oil extracted by other methods is incompatible because of different flavor.
상기 오미자 정유 및 참당귀 정유 복합물의 혼합비는 10~8:1의 중량비인 것이 바람직하며, 더 바람직하게는 10:1의 중량비이지만 이에 제한하는 것은 아니다. The mixing ratio of the Omija essential oil and the true Angelica essential oil complex is preferably 10: 8: 1, more preferably 10: 1, but is not limited thereto.
상기 조성물은 좌측 두정엽에서 RFA(Relative fast alpha power spectrum) 및 ASEF(Spectral edge frequency 50% of alpha spectrum band)의 증가를 유도하고, 우측 두정엽에서 RLB(Relative low beta power spectrum) 및 RST(Ratio of SMR to theta)의 증가를 유도하며, 좌측 전전두엽에서 SEF90(Spectral edge frequency 90%)의 감소를 유도하는 것이 특징이며, RFA 및 ASEF의 증가는 뇌파 전체에서 빠른 알파파(fast alpha wave)의 비율이 증가하는 것을 의미한다. 빠른 알파파가 증가하면 뇌를 각성시켜 집중력을 향상시키면서도 안정감과 편안함을 느낄 수 있는 상태가 된다. The composition induces an increase in RFA (relative fast alpha power spectrum) and ASEF (50% of alpha spectrum band) in the left parietal lobe and a relative low beta power spectrum (RLB) and Ratio of SMR to theta, and induces a decrease in SEF90 (90%) in the left prefrontal cortex. The increase in RFA and ASEF is attributed to an increase in fast alpha wave ratio . As the rapid increase in ALPA increases the concentration of the brain by awakening the brain, it is in a state of being able to feel stability and comfort.
RLB의 증가는 뇌파 전체에서 낮은 베타파(low beta wave)의 비율이 증가했다는 것을 의미하며, 낮은 베타파 비율의 증가는 뇌를 각성시켜 머리를 맑고, 시원하게 해주는 역할을 한다. RST의 증가는 SMR파에서 세타파(theta wave)의 비율이 증가한 것으로, 주의집중 능력이 증가한 것을 의미한다. The increase in RLB means that the ratio of low beta waves is increased in the entire EEG, and the increase in the low beta wave rate causes the brain to awaken and make the head clear and cool. The increase in RST means that the ratio of theta wave in the SMR wave is increased, which means that the attention ability is increased.
SEF90의 감소는 정신적 부하 및 스트레스의 수준을 완화시켰다는 것을 의미한다. A decrease in SEF90 means that the level of mental stress and stress has been mitigated.
상기 향료 조성물은 향수를 포함하는 화장용품, 목욕비누를 포함하는 비누세정용품, 유리 크리너를 포함하는 실내청소용품, 자동차용 방향제를 포함하는 방향용품, 허브타입 입욕제를 포함하는 목욕용품, 문구류를 포함하는 향기상품, 오피스용 방향제를 포함하는 환경용품 또는 합성수지를 포함하는 공업용품을 제조하는데 사용할 수 있다.The perfume composition may include cosmetics including perfumes, soap cleansing products including bath soaps, indoor cleaning products including glass cleaners, aroma products including car perfumes, bath products including herbal bath salts, stationery Such as perfumes, fragrances, perfumes for offices, perfumes for office use, or industrial products containing synthetic resins.
상기 향료 조성물의 제형은 특별하게 제한되지 않지만, 분말, 과립, 액상 스프레이, 고형 및 젤 타입의 제형 중에서 선택된 어느 하나일 수 있다. The formulation of the perfume composition is not particularly limited, but may be any one selected from powders, granules, liquid spray, solid and gel type formulations.
또한, 본 발명은 상기 향료 조성물을 포함하는 심리적 안정 및 스트레스 완화용 건강기능식품을 제공한다.The present invention also provides a health functional food for psychological stability and stress relief comprising the perfume composition.
상기 건강기능식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 및 천연 풍미제, 착색제 및 증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알킨산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 천연 과일 주스 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. The health functional foods include various nutrients, vitamins, minerals (electrolytes), synthetic and natural flavors, colorants and enhancers (cheese, chocolate etc.), pectic acid and its salts, alkynic acid and its salts, , pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like. It may also contain flesh for the production of natural fruit juices and vegetable drinks. These components may be used independently or in combination.
본 발명의 건강기능식품은 여러가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. The health functional food of the present invention may contain various flavors or natural carbohydrates as an additional ingredient. The natural carbohydrates are sugar saccharides such as monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like.
또한, 본 발명은 상기 향료 조성물을 포함하는 심리적 안정 및 스트레스 완화용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for psychological stability and stress relief comprising the perfume composition.
상기 화장료 조성물은 유연화장수, 수렴화장수, 영양화장수, 영양로션, 영양에센스, 영양크림, 마사지크림, 에센스, 아이크림, 아이에센스, 클렌징크림, 클렌징폼, 클렌징워터, 팩, 젤, 파우더, 메이크업베이스, 바디로션, 바디크림, 바디오일, 바디에센스, 로션, 연고, 겔, 크림, 패취 및 분무제로 이루어진 군에서 선택되는 제형인 것이 바람직하지만 이에 한정하지 않는다.
The cosmetic composition of the present invention can be used for cosmetics such as softening lotion, convergent lotion, nutritional lotion, nutrition lotion, nutrition essence, nutritional cream, massage cream, essence, eye cream, eye essence, cleansing cream, cleansing foam, cleansing water, , A body lotion, a body cream, a body oil, a body essence, a lotion, an ointment, a gel, a cream, a patch, and a spray, but is not limited thereto.
이하, 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다.
Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are merely illustrative of the present invention and that the scope of the present invention is not limited thereto.
실시예Example 1. 식물 시료 확보 및 보관 1. Acquisition and storage of plant samples
본 발명에서 사용된 오미자 및 참당귀는 강원도 평창군 진부면 하송정길 340-50 ㈜힐링네이처농업회사 법인으로부터 구입하였다. 구입한 오미자는 건조된 열매였으며, 참당귀는 건조된 뿌리의 절편이었다(도 1). The omija and chrysanthemum angustifolia used in the present invention were purchased from Heilong Nature Agriculture Company Incorporated, 340-50 Songjeong-gil, Jinbu-myeon, Pyeongchang-gun, Gangwon-do. The purchased omija was dried fruit, and Angelica angustifolia was a piece of dried root (Fig. 1).
본 실시예에서 사용된 오미자 및 참당귀를 구입할 때, ㈜힐링네치처농업회사법인으로부터 국내에서 재배되었다는 원산지 증명원을 받았으며, 연구실에 도착 즉시 4℃의 냉장고에 보관하여 휘발성 향기물질의 휘발을 억제할 수 있도록 하였고, 실험 직전에 꺼내 사용하였다.
When purchasing Omiza and Chrysanthemums used in this example, they received a Certificate of Origin that they were cultivated in Korea from the corporation of Healing Necture Agriculture Company. They were stored in a refrigerator at 4 ℃ immediately after they arrived at the laboratory to suppress the volatilization of volatile fragrance materials. And was taken out immediately before the experiment.
실시예Example 2. 천연정유의 추출 2. Extraction of natural essential oils
1) 오미자 정유의 추출1) Extraction of Omija essential oil
오미자는 후드믹서(DA280-2, DAESUNG ARTLON, Korea)를 사용하여 분쇄하였다. 본 실시예에서는 오미자 열매를 순간커트 모드에서 5초간 6회 분쇄한 오미자를 사용하였다. 분쇄된 오미자로부터의 정유 추출은 수증기 증류장치(EssenLab-Plus, HANIL LABTECH, Korea)를 사용하여 수행하였다. Omija was ground using a hood mixer (DA280-2, DAESUNG ARTLON, Korea). In this Example, Omiza obtained by pulverizing Omiza berries in an instant cut mode 6 times for 5 seconds was used. Extraction of the essential oil from the ground oyster was carried out using a steam distillation apparatus (EssenLab-Plus, HANIL LABTECH, Korea).
수증기 증류장치의 수증기 발생부위에 2ℓ의 증류수를 넣고, 정유 발생부위에 1kg의 오미자를 넣은 다음, 냉각관에는 4℃의 냉각수가 지속적으로 흐르도록 하였다. 수증기 발생부위의 온도를 100℃로 90분간 유지시키면서 수증기를 발생시켰고, 오미자에 함유된 정유는 냉각관에서 응축된 후, 수용기에서 증류수층과 정유층으로 모였다. 순수한 정유만을 모으기 위하여 정유층을 무수황산나트륨이 담겨 있는 삼각깔대기에 통과시켜 수분과 불순물을 제거시켰으며, 수집된 정유는 향취분석, 성분분석, 뇌파분석시까지 4℃의 냉장고에서 보관하였다. Two liters of distilled water was placed in the water vapor generating portion of the steam distillation apparatus, and 1 kg of omija was placed in the region where the essential oil was generated. Then, cooling water of 4 ° C was continuously flowed in the cooling tube. The water vapor was generated while maintaining the temperature of the steam generation site at 100 ° C for 90 minutes, and the essential oil contained in the ozone condensed in the cooling tube and collected in the distillation water layer and the refinery layer in the receiver. In order to collect only pure essential oil, the essential oil layer was passed through a triangular funnel containing sodium sulfate anhydrate to remove moisture and impurities. The collected essential oil was stored in a refrigerator at 4 ° C until analysis of fragrance, component analysis, and EEG analysis.
오미자 건조 열매 시료로부터 수증기증류장치를 이용하여 정유 회수율을 구하였는데, 추출된 정유의 회수율은 평균 0.57%이었으며, 표준편차는 0.04%이었다. The recovery rate of essential oil was 0.57% and the standard deviation was 0.04%.
시료
sample
평균 (%)
Average (%)
표준편차 (%)
Standard Deviation (%)
2) 참당귀 정유의 추출2) Extraction of Chrysanthemum essential oil
참당귀는 초임계 이산화탄소 추출장치(ISA-SCCO-S-050-500, ILSHIN, Korea)를 사용하여 정유를 추출하였다. 100g의 참당귀를 추출조에 넣고, 액체 이산화탄소의 압력과 온도를 각각 400bar와 50℃에서 정유를 추출하였다. The crude oil was extracted using a supercritical carbon dioxide extraction system (ISA-SCCO-S-050-500, ILSHIN, Korea). 100 g of Angelica gigas Nakai was placed in the extraction tank and the essential oil was extracted at 400 bar and 50 ° C, respectively, under the pressure and temperature of liquid carbon dioxide.
본 실시예 2에서 참당귀의 추출 압력과 온도는 선행연구(압력, 200, 300, 400 bar; 온도 40, 50, 60℃)를 통해 가장 높은 회수율을 나타내었던 조건에 따른 것이다. 최적 온도, 압력 조건에서 초임계 상태의 이산화탄소를 1 시간 동안 흘려주면서 정유를 추출하였다. 추출된 정유는 무수황산나트륨이 담겨 있는 삼각 깔대기에 통과시켜 수분과 불순물을 제거시켰으며, 수집된 정유는 향취분석, 성분분석, 뇌파분석시까지 4℃의 냉장고에서 보관하였다. In this Example 2, the extraction pressure and the temperature of the Angelica gigas are according to the condition that showed the highest recovery rate through the previous study (pressure, 200, 300, 400 bar; temperature 40, 50, 60 ° C). At the optimum temperature and pressure condition, supercritical carbon dioxide was extracted for 1 hour and the essential oil was extracted. The extracted essential oil was passed through a triangular funnel containing sodium sulfate anhydrate to remove moisture and impurities. The collected essential oils were stored in a refrigerator at 4 ° C until the analysis of the fragrance, component analysis, and EEG analysis.
참당귀 뿌리 시료로부터 초임계 이산화탄소 추출장치를 이용하여 얻은 정유의 회수율은 회수율은 평균 3.01%이었으며, 표준편차는 0.27%이었다. The recovery rate of essential oils obtained from the root samples of Angelica gigas Nakai using supercritical carbon dioxide extraction system was 3.01% and the standard deviation was 0.27%.
시료
sample
평균 (%)
Average (%)
표준편차 (%)
Standard Deviation (%)
실시예Example 3. 오미자 및 참당귀 천연정유의 향취 평가 3. Odor Evaluation of Natural Essential Oils
상기의 실시예 2에서 얻어진 오미자, 참당귀 정유의 향취 평가는 6개월 이상 후각 훈련이 되어 있는 강원대학교 향수개발동아리 Rose of Sharon의 전문패널 5명에 의해 수행되었다. 상기 실시예 2에서 추출된 오미자와 참당귀 천연정유 원액(100%)을 시향지(0.5cm×5cm)에 적신 다음, 패널의 코로부터 5cm 위치에 시향지를 위치시켜 향을 맡으면서 향의 특징을 향료 평가 용어(표 3)를 이용하여 기술하였다. 관능평가에 사용된 향취타입은 알데하이드(aldehyde), 애니마릭(animalic), 발사믹(balsamic), 시트러스(citrus), 코니퍼로스(coniferous), 얼띠(earthy), 플로랄(floral), 푸루티(fruity), 그린(green), 허벌(herbal), 메디시날(medicinal), 민티(minty), 마린(marine), 모씨(mossy), 머스키(musky), 오일리(oily), 오리엔탈(oriental), 파우더리(powdery), 스모키(smoky), 스파이시(spicy), 스위트(sweet), 우디(woody)였으며, 통상적으로 향취 평가 전문가 집단이 사용하는 것을 사용하였다.
The aroma evaluation of the Omija and Angelica japonica essential oils obtained in Example 2 above was carried out by five expert panels of Rose of Sharon, a perfume development club member of Kangwon University, which has been training for more than six months. (100%) of Omija and Angelica japonica extract extracted from Example 2 were wetted on a shade paper (0.5 cm × 5 cm), and then the shade paper was placed at a position of 5 cm from the nose of the panel. And the fragrance evaluation term (Table 3). The flavor types used in the sensory evaluation were aldehyde, animalic, balsamic, citrus, coniferous, earthy, floral, fruity, ), Green, herbal, medicinal, minty, marine, mossy, musky, oily, oriental, Powdery, smoky, spicy, sweet, and woody, typically used by a group of flavor assessment experts.
본 실시예 3에서 수증기 증류기를 사용하여 추출된 오미자 정유의 향취는 애니멀릭(animalic), 발사믹(balsamic), 시트러스(citrus), 얼씨(earthy), 플로럴(floral), 프루티(fruity), 그린(green), 메디시날(medicinal), 오일리(oily), 스위트(sweet), 우디(woody)한 것으로 평가되었다(표 4). The aroma of Omija essential oil extracted using the steam distiller in this Example 3 can be obtained from animalic, balsamic, citrus, earthy, floral, fruity, green, medicinal, oily, sweet, and woody (Table 4).
또한 초임계 이산화탄소 추출기를 사용하여 추출된 참당귀 정유의 향취는 발사믹(balsamic), 얼씨(earthy), 허벌(herbal), 메디시날(medicinal), 오리엔탈(oriental), 스파이시(spicy), 스위트(sweet)한 것으로 평가되었다(표 4).In addition, the fragrance of the true Angelica essential oil extracted using the supercritical carbon dioxide extractor can be obtained from balsamic, earthy, herbal, medicinal, oriental, spicy, sweet) (Table 4).
실시예Example 4. 오미자, 참당귀 천연정유를 이용한 조합향료 개발 및 선호도 조사 4. Development and Preference of Combination Spices Using Natural Essential Oil
상기의 실시예 2에서 오미자 열매를 수증기 증류로 추출한 정유와 참당귀 뿌리를 초임계 이산화탄소로 추출한 정유를 조합하여 새로운 조합향료 3종을 개발하였다(표 5). 오미자 정유와 참당귀 정유는 고유의 독특한 향취가 있으며, 혼합 시 오미자와 참당귀 정유의 향취와는 전혀 다른 독특한 향취를 나타내었다. In Example 2, three kinds of new combination fragrances were developed by combining the essential oil extracted with steam distillation and the essential oil extracted with supercritical carbon dioxide (Table 5). The omija essential oil and the true angelic essential oil have their own unique fragrance and have a distinctive flavor completely different from that of the omija and the true angelic essential oil when mixed.
조합향료 3종에 대한 선호도 조사를 최소 6개월 이상의 후각훈련이 되어 있는 강원대학교 향수개발 동아리 Rose of Sharon 전문가 패널 10명이 수행하였는데 본 실시예 4에 참여한 패널들은 모두 20대였다. 각각의 조합향료 원액(100%)을 시향지(0.5cm×5cm)에 적신 다음, 패널의 코로부터 5cm 위치에 시향지를 위치시켜 향을 맡고 가장 선호하는 향료에 10점, 가장 비선호하는 향료에 1점을 주도록 하였다. 선호도 결과를 바탕으로 평균값을 구하였고, 이를 표 5에 나타내었다. 10 of Rose of Sharon Expert Panel participated in Kangwon University Perfume Development Circle which had at least 6 months olfactory training for preference survey on three kinds of combined fragrance. Each of the combined fragrance stock solutions (100%) was soaked in a tissue paper (0.5 cm × 5 cm), and then placed in a position 5 cm from the nose of the panel to position the scent paper. The perfume was scored 10 points on the most preferred fragrance, Points were given. Table 5 shows the average values based on the preference results.
오미자 정유에 대한 소비자 선호도는 5.0이었으며, 참당귀 정유에 대한 소비자 선호도는 5.7이었다. 오미자 정유와 참당귀 정유에 대한 소비자 선호도 결과를 바탕으로 2종 천연정유는 소비자들에게 무난하게 받아들여질 것이라 판단되었다. Consumer preference for Omija essential oil was 5.0, and consumer preference for true Angelica essential oil was 5.7. Based on consumer preference results for Omija refined oil and true angel oil refined oil, it was judged that the two kinds of natural refined oil will be acceptable to consumers.
오미자 정유와 참당귀 정유를 조합한 조합향료 1, 2, 3의 소비자 선호도 조사 결과는 4.6, 5.0, 5.5로 20대 소비자들은 조합향료 3을 가장 선호하는 것으로 나타났다(표 5). Consumer preference scores of the combination spices 1, 2, and 3, which consisted of the combination of Omija essential oil and Chrysanthemum essential oil, were 4.6, 5.0, and 5.5, respectively.
(평균값)Consumer preference
(medium)
실시예Example 5. 조합향료 3이 뇌파에 미치는 영향 5. Effect of Combination Fragrance 3 on EEG
실시예 4의 조합향료 3에 무수 에탄올을 가해 2%로 희석한 희석액(이하 '조합향료 3'이라 칭하였다)을 조제하였다. A diluted solution (hereinafter referred to as 'combined fragrance 3') diluted to 2% by adding anhydrous ethanol to the combined fragrance 3 of Example 4 was prepared.
본 실시예 5에서는 조합향료 3의 흡입이 인간의 뇌에 어떠한 영향을 미치는지를 알고자 뇌파를 측정하였다. 뇌파 측정은 최대한 잡음이 혼입되지 않은 온도 23℃, 습도 50%가 유지되는 32.4㎡ 크기의 실험실에서 남, 녀 각각 6명 총 12명의 피험자를 대상으로 수행하였다. In Example 5, brain waves were measured in order to know how the inhalation of the combined fragrance 3 affected the human brain. EEG measurements were performed on 12 subjects (6 men and 6 women) in a 32.4 - square - meter laboratory, where temperature and humidity were maintained at 23 ℃ and 50% humidity, respectively.
본 실시예 5에서 뇌파측정을 위해 사용한 뇌파 측정기기는 QEEG-8 System(LXE3208, LAXTHA Inc. Korea)이었으며, 피험자의 뇌파신호 측정은 LAXTHA의 데이터 수집 장비 및 분석프로그램(Telescan)을 이용하였다. 피험자들에게 10~20 국제표준 전극 부착법을 이용하여 8개의 접지전극을 뇌파전용 Electro-Gel(Electro-Cap Internationals, Inc. U.S.A.)을 사용하여 좌측과 우측 전전두엽 (Fp1, Fp2), 좌측과 우측 전두엽 (F3, F4), 좌측과 우측 측두엽 (T3, T4), 좌측과 우측 두정엽 (P3, P4) 부분에 부착하고 오른쪽과 왼쪽 귓볼 뒷부분에도 각각 하나씩의 전극(CovidienTM)을 부착하였다(도 2). The EEG measurement device used for EEG measurement was QEEG-8 System (LXE3208, LAXTHA Inc. Korea) and EEG signals were measured using LAXTHA data acquisition equipment and analysis program (Telescan). Electro-Cap Internationals, Inc., USA) was used for electroencephalography (EEG), and the left and right frontal lobes (Fp1, Fp2), left and right frontal lobes (Fig. 2) were attached to the left and right temporal lobes (T3 and T4), left and right parietal lobes (P3 and P4), and one electrode (Covidien TM ) .
윗면 지름 5cm, 높이 4.8cm, 아랫면 지름 3.5cm의 종이컵에 가로 3.5cm, 세로 4cm의 거즈를 넣고 피펫을 이용해 정유를 첨가하여 거즈에 고루 묻힌 후, 피험자의 코로부터 약 5cm 거리를 유지하고 피험자가 눈을 감은 상태에서 향 흡입 전(무자극)과 흡입 상태(향자극)로 하여 각각 45초씩 측정하였다. 본 실시예 5에서 조합향료 3의 희석액에 대한 뇌파측정을 통해 얻어진 데이터 처리는 피험자의 뇌파신호 중 대표적인 30초간의 뇌파신호만을 추출하여 뇌파 일괄처리 프로그램(batch processing)으로 수행한 후, 통계분석 소프트웨어 프로그램인 SPSS(SPSS 18.0 version)를 이용하여 대응표본 T 검정을 수행하였다.In a paper cup of 5 cm in height, 4.8 cm in height, and 3.5 cm in diameter on the top, gauze of 3.5 cm in length and 4 cm in length was placed and added to the gauze using a pipette to maintain the distance from the subject's nose to about 5 cm. The eyes were closed for 45 seconds before incense inhalation (irritation) and inhalation (incense irritation), respectively. In the data processing obtained through EEG measurement for the diluted solution of the combined fragrance 3 in the fifth embodiment, only a representative 30-second electroencephalogram signal among the EEG signals of the test subject was extracted and subjected to an EEG batch processing, A corresponding sample T test was performed using the SPSS program (SPSS 18.0 version).
본 실시예 5에서 조합향료 3의 흡입 전(무자극)과 흡입 중(향자극)에 얻는 데이터 분석을 위한 뇌파지표의 종류는 표 6에 나타냈고, 각각의 뇌파 지표의 의미는 표 7에 나타내었다.Table 6 shows the types of EEG indicators for data analysis obtained before inhalation (unstimulated) and during inhalation (incense stimulation) of Combination Fragrance 3 in Example 5, and the meanings of the EEG indices are shown in Table 7 .
본 실시예 5에서 25개의 뇌파분석 지표 중 RFA(Relative fast alpha power spectrum), RLB(Relative low beta power spectrum), RST(Ratio of SMR to theta), SEF90(Spectral edge frequency 90%), ASEF(Spectral edge frequency 50% of alpha spectrum band) 지표에서만 무자극과 향자극 간에 통계학적인 유의 차가 나타났으며(p<0.05), 나머지 지표들에서는 차이가 없는 것으로 나타났다.
In the fifth embodiment, among the 25 EEG analysis indexes, a relative fast alpha power spectrum (RFA), a relative low beta power spectrum (RLB), a Ratio of SMR to theta, a spectral edge frequency 90% There was a statistically significant difference (p <0.05) between the unstimulated and incongruent stimuli only at the edge frequency of 50% of the alpha spectrum band.
1) RFA(Relative fast alpha power spectrum) 지표1) Relative fast alpha power spectrum (RFA)
조합향료 3의 흡입으로 피험자들의 RFA 지표가 좌측 두정엽(P3)에서 0.1629에서 0.1914로 통계적으로 유의하게 증가하였다(표 8). The RFA indices of subjects with statistical significance increased from 0.1629 to 0.1914 in the left parietal lobe (P3) with the inhalation of combination fragrance 3 (Table 8).
RFA 지표는 뇌파 스펙트럼에서 전체 주파수 대역의 절대 파워를 기준으로 각 주파수의 절대 파워를 비율로 계산한 값으로 fast 알파파영역(11~13Hz)을 전체 주파수 영역(4~50Hz)으로 나누어준 스펙트럼 값을 의미한다. The RFA index is a ratio of the absolute power of each frequency based on the absolute power of the entire frequency band in the EEG spectrum. It is a spectrum value obtained by dividing the fast ALPHA region (11 ~ 13Hz) into the entire frequency region (4 ~ 50Hz) .
본 실시예 5에서 RFA 지표의 증가는 조합향료 3이 뇌를 각성시켜 집중시키면서도 안정하게 편안함을 느끼게 하여 심리적 안정을 유도한다는 것을 나타낸다. The increase in the RFA index in Example 5 indicates that the combination perfume 3 induces psychological stability by making the brain feel more comfortable while concentrating and concentrating the brain.
Fp1: 좌측 전전두엽(left prefrontal), Fp2: 우측 전전두엽(Right prefrontal), F3: 좌측 전두엽(Left frontal), F4: 우측 전두엽(Right frontal), T3: 좌측 측두엽(Left tomporal), T4: 우측 측두엽(Right temporal), P3: 좌측 두정엽(left parietal), P4: 우측 두정엽(Right parietal)
Fp1: left prefrontal, Fp2: right prefrontal, F3: left frontal, F4: right frontal, T3: left tomporal, T4: right temporal Right temporal), P3: left parietal, P4: right parietal,
2) 조합향료 3의 흡입으로 인한 RLB(Relative low beta power spectrum) 지표 변화2) Relative low beta power spectrum (RLB) index change due to inhalation of combination fragrance 3
조합향료 3의 흡입은 피험자들의 우측 두정엽(P4)에서의 RLB 지표를 증가시켰다(표 9). Inhalation of the combined fragrance 3 increased the RLB indices in the right parietal lobe (P4) of the subjects (Table 9).
RLB 지표는 뇌파 스펙트럼에서 전체 주파수 영역의 절대 파워에 대한 낮은 베타(low beta) 대역의 절대 파워비로서, 낮은 베타(low beta)파 영역(12~15Hz)을 전체 주파수 영역(4~50Hz)으로 나누어준 스펙트럼 값으로, RLB 지표가 증가했다는 것은 본 발명의 조합향료 3이 뇌를 각성시켰다는 것을 의미한다. The RLB index is an absolute power ratio of the low beta band to the absolute power of the entire frequency region in the EEG spectrum and is defined as the ratio of the low beta waveband (12 to 15 Hz) to the entire frequency band (4 to 50 Hz) With the spectral value divided, the increase in the RLB index means that the combination perfume 3 of the present invention awakens the brain.
Fp1: 좌측 전전두엽(left prefrontal), Fp2: 우측 전전두엽(Right prefrontal), F3: 좌측 전두엽(Left frontal), F4: 우측 전두엽(Right frontal), T3: 좌측 측두엽(Left tomporal), T4: 우측 측두엽(Right temporal), P3: 좌측 두정엽(left parietal), P4: 우측 두정엽(Right parietal)
Fp1: left prefrontal, Fp2: right prefrontal, F3: left frontal, F4: right frontal, T3: left tomporal, T4: right temporal Right temporal), P3: left parietal, P4: right parietal,
3) 조합향료 3의 흡입으로 인한 RST(Ratio of SMR to theta) 지표 변화3) Ratio of SMR to theta due to inhalation of combination fragrance 3
조합향료 3의 흡입으로 피험자들의 우측 두정엽(P4)에서 RST 지표가 0.5873에서 0.9416으로 증가하였으며, 통계적으로 유의미하다는 것을 확인하였다(표 10). The RST index increased from 0.5873 to 0.9416 in the right parietal lobe of subjects (P4) by inhalation of the combined fragrance 3 and was found to be statistically significant (Table 10).
RST는 뇌파 스펙트럼에서 SMR/theta의 비율로 SMR파 영역(12~15Hz)을 세타(theta)파 영역(4~8Hz)으로 나누어 준 스펙트럼 값을 의미하며, 주변 상황을 경계하는 주의능력을 나타내는 뇌파분석 지표이다. 본 실시예 5에서 RST 지표가 증가하였다는 것은 조합향료 3의 흡입으로 주의집중 능력이 증가하였다는 것을 의미한다. RST is the spectral value obtained by dividing SMR wave region (12 ~ 15Hz) by theta wave region (4 ~ 8Hz) at the ratio of SMR / theta in the EEG spectrum, It is an analysis index. The increase in the RST index in Example 5 means that the attention concentrating ability of the combination perfume 3 is increased by inhalation.
Fp1: 좌측 전전두엽(left prefrontal), Fp2: 우측 전전두엽(Right prefrontal), F3: 좌측 전두엽(Left frontal), F4: 우측 전두엽(Right frontal), T3: 좌측 측두엽(Left tomporal), T4: 우측 측두엽(Right temporal), P3: 좌측 두정엽(left parietal), P4: 우측 두정엽(Right parietal)
Fp1: left prefrontal, Fp2: right prefrontal, F3: left frontal, F4: right frontal, T3: left tomporal, T4: right temporal Right temporal), P3: left parietal, P4: right parietal,
4) 조합향료 3의 흡입으로 인한 SEF90(spectral edge frequency 90%) 지표 변화4) SEF90 (spectral edge frequency 90%) due to inhalation of the combination fragrance 3
조합향료 3의 흡입은 피험자들의 SEF90(spectral edge frequency 90%) 지표를 좌측 전전두엽(Fp1)에서 감소시켰다(표 11). 두뇌 스트레스의 일반적인 지표인 SEF 90는 과제를 수행할 때 느끼는 인지 부하도 즉, 정신적인 스트레스 수준 및 과도한 정신적 각성 수준을 나타내는데 본 실시예 5에서 SEF90 지표가 감소했다는 것은 조합향료 3이 스트레스 수준을 완화시켰다는 것을 의미하며 피험자들은 심리적으로 안정되었다는 것을 의미한다. Inhalation of the combined fragrance 3 reduced the SEF90 (spectral edge frequency 90%) indicator of the subjects in the left prefrontal cortex (Fp1) (Table 11). SEF 90, which is a general indicator of brain stress, shows the cognitive load felt during the task, namely, mental stress level and excessive mental arousal level. The decrease in the SEF90 index in Example 5 indicates that Combination Spice 3 mitigates the stress level And the subjects were psychologically stable.
Fp1: 좌측 전전두엽(left prefrontal), Fp2: 우측 전전두엽(Right prefrontal), F3: 좌측 전두엽(Left frontal), F4: 우측 전두엽(Right frontal), T3: 좌측 측두엽(Left tomporal), T4: 우측 측두엽(Right temporal), P3: 좌측 두정엽(left parietal), P4: 우측 두정엽(Right parietal)
Fp1: left prefrontal, Fp2: right prefrontal, F3: left frontal, F4: right frontal, T3: left tomporal, T4: right temporal Right temporal), P3: left parietal, P4: right parietal,
5) 조합향료 3의 흡입으로 인한 ASEF(spectral edge frequency 50% of alpha spectrum band) 지표 변화5) ASEF (spectral edge frequency 50% of alpha spectrum band) change due to inhalation of combination fragrance 3
본 실시예 5에서 조합향료 3의 흡입으로 피험자들의 ASEF 지표는 좌측 두정엽(P3)에서 통계적으로 의미 있게 증가한 것을 확인하였다(표 12). ASEF 지표는 알파파의 SEF50으로 쾌적성을 나타내는 뇌파 지표로, 몸과 마음의 이완을 의미하는데, 본 실시예 5에서 조합향료 3이 ASEF 지표를 증가시킨다는 것은 심신을 안정화시킨다는 것을 의미한다. In this Example 5, the ASEF index of subjects was statistically significantly increased in the left parietal lobe (P3) by inhalation of the combined fragrance 3 (Table 12). The ASEF index is an EEG index showing comfort with SEP 50 of ALPHA, which means relaxation of the body and mind. In this Example 5, the combination perfume 3 increases the ASEF index, which means that the mind and body are stabilized.
Fp1: 좌측 전전두엽(left prefrontal), Fp2: 우측 전전두엽(Right prefrontal), F3: 좌측 전두엽(Left frontal), F4: 우측 전두엽(Right frontal), T3: 좌측 측두엽(Left tomporal), T4: 우측 측두엽(Right temporal), P3: 좌측 두정엽(left parietal), P4: 우측 두정엽(Right parietal)Fp1: left prefrontal, Fp2: right prefrontal, F3: left frontal, F4: right frontal, T3: left tomporal, T4: right temporal Right temporal), P3: left parietal, P4: right parietal,
Claims (9)
The cosmetic composition according to claim 8, wherein the cosmetic composition is at least one selected from the group consisting of softening agents, convergent lotion, nutritional lotion, nutritional lotion, nutritional essence, nutritional cream, massage cream, essence, eye cream, eye essence, cleansing cream, cleansing foam, Wherein the composition is selected from the group consisting of a gel, a powder, a makeup base, a body lotion, a body cream, a body oil, a body essence, a lotion, an ointment, a gel, a cream, a patch and a spray.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160112927A KR101714543B1 (en) | 2016-09-02 | 2016-09-02 | Aroma composition for psycholigical stability and reducing stress comprising Schisandra chinensis essential oil and Angelica gigas essential oil as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160112927A KR101714543B1 (en) | 2016-09-02 | 2016-09-02 | Aroma composition for psycholigical stability and reducing stress comprising Schisandra chinensis essential oil and Angelica gigas essential oil as effective component |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101714543B1 true KR101714543B1 (en) | 2017-03-13 |
Family
ID=58412007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160112927A KR101714543B1 (en) | 2016-09-02 | 2016-09-02 | Aroma composition for psycholigical stability and reducing stress comprising Schisandra chinensis essential oil and Angelica gigas essential oil as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101714543B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107157874A (en) * | 2017-05-16 | 2017-09-15 | 中国农业科学院特产研究所 | A kind of Chinese medicine composition and its application and cosmetics |
KR20180041388A (en) * | 2016-10-14 | 2018-04-24 | 주식회사 팜크로스 | Aroma composition with grape flavor containing essential oil of Schisandra chinensis and Angelica gigas for enhancing concentration state and uses thereof |
CN108714112A (en) * | 2018-06-12 | 2018-10-30 | 无限极(中国)有限公司 | Composition and the moisturizing containing the composition and/or oxidation resistant cosmetics |
KR20190026317A (en) * | 2017-09-05 | 2019-03-13 | 서울대학교산학협력단 | Composition for Pain Relief Comprising Natural Combined Oil |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990070812A (en) * | 1998-02-24 | 1999-09-15 | 조원기 | Functional stress relief drink |
KR20040040222A (en) * | 2002-11-06 | 2004-05-12 | 주식회사 경인제약 | Yeast hydrolysate comprising Angelica Gigantis Nakai having anti-stress, anti-fatigue, and neurotrophic activities |
KR100522579B1 (en) * | 2004-04-30 | 2005-10-19 | (주) 한약마을 | Pharmaceutical composition comprising the extracts of scutellaria root and schizandra fruit mixture thereof having an effect of restraint stress |
KR101349592B1 (en) * | 2013-05-22 | 2014-02-13 | 김성문 | Fragrance chemicals on relaxation and comfortable states of brain function by decreasing beta wave at left prefrontal region and spectral edge frequency 50% value at right preforntal region |
-
2016
- 2016-09-02 KR KR1020160112927A patent/KR101714543B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990070812A (en) * | 1998-02-24 | 1999-09-15 | 조원기 | Functional stress relief drink |
KR20040040222A (en) * | 2002-11-06 | 2004-05-12 | 주식회사 경인제약 | Yeast hydrolysate comprising Angelica Gigantis Nakai having anti-stress, anti-fatigue, and neurotrophic activities |
KR100522579B1 (en) * | 2004-04-30 | 2005-10-19 | (주) 한약마을 | Pharmaceutical composition comprising the extracts of scutellaria root and schizandra fruit mixture thereof having an effect of restraint stress |
KR101349592B1 (en) * | 2013-05-22 | 2014-02-13 | 김성문 | Fragrance chemicals on relaxation and comfortable states of brain function by decreasing beta wave at left prefrontal region and spectral edge frequency 50% value at right preforntal region |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180041388A (en) * | 2016-10-14 | 2018-04-24 | 주식회사 팜크로스 | Aroma composition with grape flavor containing essential oil of Schisandra chinensis and Angelica gigas for enhancing concentration state and uses thereof |
KR101877290B1 (en) * | 2016-10-14 | 2018-07-11 | 주식회사 팜크로스 | Aroma composition with grape flavor containing essential oil of Schisandra chinensis and Angelica gigas for enhancing concentration state and uses thereof |
CN107157874A (en) * | 2017-05-16 | 2017-09-15 | 中国农业科学院特产研究所 | A kind of Chinese medicine composition and its application and cosmetics |
KR20190026317A (en) * | 2017-09-05 | 2019-03-13 | 서울대학교산학협력단 | Composition for Pain Relief Comprising Natural Combined Oil |
KR101962894B1 (en) * | 2017-09-05 | 2019-07-31 | 서울대학교산학협력단 | Composition for Pain Relief Comprising Natural Combined Oil |
CN108714112A (en) * | 2018-06-12 | 2018-10-30 | 无限极(中国)有限公司 | Composition and the moisturizing containing the composition and/or oxidation resistant cosmetics |
CN108714112B (en) * | 2018-06-12 | 2021-04-27 | 无限极(中国)有限公司 | Composition and moisturizing and/or antioxidant cosmetic containing same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101855737B1 (en) | Aroma composition with buleberry flavor for relaxation and uses thereof | |
KR101714543B1 (en) | Aroma composition for psycholigical stability and reducing stress comprising Schisandra chinensis essential oil and Angelica gigas essential oil as effective component | |
KR101077018B1 (en) | Cosmetic Composition with Anti-stress and Relaxing Effect | |
KR20120131970A (en) | Perfume composition with antistress and relexing effect, and cosmetic composition comprising the same | |
KR102151761B1 (en) | Aquatic aroma composition for relaxation and enhancing concentration of human brain and uses thereof | |
KR102275549B1 (en) | Aromatic composition containing extract of hydrangea serrata for psychological relaxation | |
KR102118555B1 (en) | Nano liposome herbal complex extract composition having relaxation and sleep promoting effect and preparation method thereof | |
KR102060958B1 (en) | Tropical passion flower aroma composition for enhancing concentration of human brain and uses thereof | |
KR102060957B1 (en) | Deep forest mix aroma composition for enhancing concentration of human brain and uses thereof | |
KR101533673B1 (en) | Perfume composition for expressing the fragrance of gardenia jasminoides Ellis for. Grandiflora Makino | |
KR102060960B1 (en) | Aroma composition having fragrance of sensual luminous flower for brain pleasant and comfort | |
KR101922466B1 (en) | Method for producing Hydrangea macrophylla tea having attention and concentration strengthening effect | |
KR102570019B1 (en) | A foot massage composition for aromatherapy | |
KR102151758B1 (en) | Aromatic aroma composition for enhancing concentration of human brain and uses thereof | |
KR101877290B1 (en) | Aroma composition with grape flavor containing essential oil of Schisandra chinensis and Angelica gigas for enhancing concentration state and uses thereof | |
KR102506624B1 (en) | Fruity floral Abies koreana aroma composition for enhancing concentration of human brain | |
KR102506628B1 (en) | Aqua green Abies koreana aroma composition for enhancing comfort and concentration of human brain | |
KR102124581B1 (en) | Composition for mental and physical rest containing distilled-extracts of mountain-cultivated ginseng | |
KR101313255B1 (en) | Fragrance compound containing the essential oil from Heracleum moellendorffii | |
KR101577643B1 (en) | Perfume composition for expressing the fragrance of j smilax china l. | |
KR102244814B1 (en) | A composition for relieving stress including pelargonium graveolens oil | |
KR102266870B1 (en) | A relax doll | |
KR102570858B1 (en) | A skin massage composition for aromatherapy | |
KR20190101264A (en) | Fragrance composition for anti-stress comprising fragrance of regions | |
KR20130122043A (en) | Composition of atractylodes ovata (thunb.) dc essential oil and cosmetic having there |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
E90F | Notification of reason for final refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20191230 Year of fee payment: 4 |